Startseite Medizin Adverse Effect of Phenytoin on Glucocorticoid Replacement in a Child with Adrenal Insufficiency
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Adverse Effect of Phenytoin on Glucocorticoid Replacement in a Child with Adrenal Insufficiency

  • Cengiz Kara , Ahmet Ucaktürk , Ömer Faruk Aydin und Murat Aydin
Veröffentlicht/Copyright: 22. Dezember 2010
Journal of Pediatric Endocrinology and Metabolism
Aus der Zeitschrift Band 23 Heft 9

ABSTRACT

Chronic administration of antiepileptic agents such as phenytoin can increase clearance rates of cortisol and synthetic glucocorticoids through hepatic microsomal enzyme induction. However, data concerning an adverse interaction between antiepileptic and steroid drugs are scarce. We herein report an adolescent boy with primary adrenal insufficiency that developed glucocorticoid deficiency after added phenytoin treatment. The patient had an increased requirement for hydrocortisone replacement, and two episodes of vomiting, hyponatremia and mild hypoglycemia. His ACTH levels were markedly elevated. Fifteen days after stopping phenytoin, his serum ACTH concentration returned to normal range. Even though the hydrocortisone dose was gradually decreased, hyponatremia and vomiting have not recurred. In conclusion, we suggest that drugs such as phenytoin affecting hepatic clearance of synthetic glucocorticoids and mineralocorticoids should not be preferred for therapy in patients with adrenal insufficiency. If their use is vital, one should be aware of increased replacement requirements for steroid drugs, and patients should be closely monitored.


Corresponding Author: Cengiz Kara, MD,

Published Online: 2010-12-22
Published in Print: 2010-September

© Freund Publishing House Ltd.

Artikel in diesem Heft

  1. The Soy That Surrounds Us: An Endless Debate
  2. Soy as an Endocrine Disruptor: Cause for Caution?
  3. Mass Ascites in Mulibrey Nanism
  4. Delayed Gastric Emptying in Patients with Prader Willi Syndrome
  5. Age and Sex Differences in Fat Distribution in Non-Obese Japanese Children
  6. Premature Thelarche in Taiwanese Girls
  7. Growth Hormone, Insulin Like Growth Factor-1, and Insulin-like Growth Factor-Binding Protein-3 Levels in the Neonatal Period: A Preliminary Study
  8. Bone Maturation in 1788 Children and Adolescents with Diabetes Mellitus Type 1
  9. Serum Thyroid Hormone Levels in Preterm Infants Born before 33 Weeks of Gestation and Association of Transient Hypothyroxinemia with Postnatal Characteristics
  10. Birth Length is a Predictor of Adiponectin Levels in Japanese Young Children
  11. Genotype-Phenotype Correlation in CAH Patients with Severe CYP21A2 Point Mutations in the Republic of Macedonia
  12. Benign Transient Hyperphosphatasemia of Infancy. A Common Benign Scenario, a Big Concern for a Pediatrician
  13. Scarcity Despite Wealth: Osteopetrorickets
  14. Growth Hormone Therapy and the Risk of Tumor Recurrence after Brain Tumor Treatment in Children
  15. Insulin Resistance and the Metabolic Syndrome in Obese Children Referred to an Obesity Center
  16. Severe Dietary Protein Sensitivity and Hyperinsulinemic Hypoglycemia in a Patient with Heterozygous Mutation in HADH Gene
  17. Neonatal Autoimmune Hypothyroidism: A Patient Report
  18. Adverse Effect of Phenytoin on Glucocorticoid Replacement in a Child with Adrenal Insufficiency
  19. Investigation of Acquired Von Willebrand Syndrome in Children with Hypothyroidism: Reversal after Treatment with Thyroxine
  20. Kabuki Syndrome and Crohn Disease in a Child with Familial Hypocalciuric Hypercalcemia
Heruntergeladen am 11.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem.2010.154/html
Button zum nach oben scrollen